
Mebeverine Pellets - 135 Mg Sustained Release Capsule, Red Color | Drug Layering Process With Umang Pharmatech Equipment
Price:
Get Latest Price
In Stock
Product Specifications
| Active Ingredient | Mebeverine |
| Dosage Forms | Pellets |
| Release Type | Multiple |
| Packaging | Bulk |
| Strength | Variable |
| Manufacturing Method | Drug Layering |
| Usage | Treats irritable bowel syndrome and gastrointestinal spasms |
| Features | Antispasmodic, IBS treatment, Gastrointestinal relief, No atropic effects, Effective, Reliable |
Product Overview
Key Features
It is also indicated for treatment of gastrointestinal spasm secondary to organic disorder. It was first registered in 1965.
It is manufactured and marketed as Colofac, Duspatal and Duspatalin by Solvay Pharmaceuticals.
Mebeverine is presented in the United Kingdom as a (135 mg) tablet. Other strengths: 100 mg tablet and 200 mg capsule.
Availble Form:
We also offer Sustained (SR) / Immediate (IR) / Timed (TR) / Controlled (CR) / Delayed Release (DR) and Enteric Coated (EC).
Umang Pharmatech equipments used for production of Mebeverine Pellets:
DRUG LAYERING : Mebeverine pellets can be made by Drug layering method by a suitable drug layering equipment Made by UMANG PHARMATECH, The powder is sprinkled from one side in a drug layering machine and liquid from the other side.
Company Details
Focusing on a customer-centric approach, UMANG GLOBAL GROUP PVT LTD has a pan-India presence and caters to a huge consumer base throughout the country. Buy Pharmaceutical Raw Materials & Ingredients in bulk from UMANG GLOBAL GROUP PVT LTD at Trade India quality-assured products.
Business Type
Exporter, Manufacturer, Supplier, Trading Company
Employee Count
100
Establishment
1982
Working Days
Monday To Saturday
GST NO
27AAACU4157H1ZA
Related Products
More Products From This Seller
Seller Details
GST - 27AAACU4157H1ZA
Mumbai, Maharashtra
CEO
Mr Umang Budhraja
Address
Unit No. 1, 2nd Floor, Vicino (Mega Mall), New link road, Oshiwara, Andheri West, Mumbai, Maharashtra, 400102, India
Report incorrect details





















